DeutschNewstral
Article
Bbarrons.com on 2021-06-07 20:49
Biogen Stock Jumps on FDA Approval
Related news
- BBiogen Stock Jumps on FDA Approvalbarrons.com
- MFDA chief tells reporters “transfer on” when pushing for approval of Biogen Alzheimer’smvtelegraph.com
Clinuvel Pharma jumps 47pc on FDA approvalSydney Morning Herald- MLa Jolla stock jumps 16% after FDA approvalmarketwatch.com
BioNTech Stock Jumps Thanks To Imminent FDA Vaccine ApprovalForbes- BAfter Lengthy Delay, Biogen Submits Troubled Alzheimer’s Drug for FDA Approvalbarrons.com
- MBiogen talks up approval plans for controversial Alzheimer's drug as it nears FDA decisionmarketwatch.com
- BBiogen Stock Can Go 'Decisively Higher' on Sales of Alzheimer's Drug2 min readbarrons.com
Biogen loses edge on blockbuster rare disease market with Novartis' FDA approvalbizjournals.com- BBiogen Stock Gains Before Anticipated FDA Decisionbarrons.com
- BFDA Will Weigh Full Approval for Alzheimer's Drug. Why It Matters for Biogen Stock. 3 min readbarrons.com
- MEpizyme's stock jumps on 11-0 vote from FDA adcommmarketwatch.com
- MHorizon's stock jumps on FDA adcomm support for eye drugmarketwatch.com
- BSarepta Could Triple on Expedited FDA Approvalbarrons.com
- MSeattle Genetics stock jumps 6% after new FDA approval for lymphoma treatmentmarketwatch.com
- MLilly's COVID-19 treatment receives emergency-use approval from FDA, stock jumps 3%marketwatch.com
- MAbbVie stock ticks higher on FDA approval of psoriasis treatmentmarketwatch.com
- MNeurocrine's stock is up on FDA approval of Parkinson's drugmarketwatch.com
- BNeos Therapeutics stock soars on FDA approval for ADHD drugbizbeatblog.dallasnews.com